HCA Healthcare, Inc. (NYSE:HCA) SVP Sells $1,363,950.00 in Stock

HCA Healthcare, Inc. (NYSE:HCA) SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

HCA Healthcare Price Performance

HCA Healthcare stock traded down $3.96 during midday trading on Thursday, hitting $345.36. 1,835,701 shares of the company’s stock were exchanged, compared to its average volume of 1,183,271. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock has a 50-day moving average price of $387.05 and a two-hundred day moving average price of $357.11. HCA Healthcare, Inc. has a 52-week low of $237.57 and a 52-week high of $417.14. The company has a market cap of $87.48 billion, a P/E ratio of 15.79, a PEG ratio of 1.35 and a beta of 1.68.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.76%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Institutional Investors Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its stake in shares of HCA Healthcare by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after acquiring an additional 60,304 shares during the last quarter. FMR LLC lifted its stake in shares of HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares during the last quarter. Capital World Investors lifted its stake in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after purchasing an additional 41,190 shares during the period. Finally, Darsana Capital Partners LP increased its holdings in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on HCA shares. Wells Fargo & Company lifted their price target on HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 6th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Oppenheimer raised their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Finally, Royal Bank of Canada lifted their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Five analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.